FBXO32 and lung adenocarcinoma: In our follow-up study, we plan to design a small molecule inhibitor of FBXO32 and construct an in vivo model in nude mice to investigate whether the small molecule inhibitor of FBXO32 can inhibit the progression of lung adenocarcinoma, in order to enhance the persuasiveness of FBXO32 as a feasible therapeutic target for lung adenocarcinoma.